Why GCMI for your medtech design & development needs? We have established a proven, capital-efficient pathway and process.

A medtech or life science project’s success is dependent on the careful consideration of several intersecting components: technological, clinical, commercial and legal. GCMI follows a structured, phase-gated process that allows for a disciplined, capital efficient medical device design and product development approach.

Increasing Availability of Lateral Access Spinal Surgery Training: Georgia Tech Spring 2021 Capstone Design Expo’s “Vertebros”

Lateral access has become the preferred, minimally invasive method for lumbar spinal surgery. Entering the torso from the side significantly shortens patient recovery times and lessens tissue trauma thanks to a smaller incision requirement.   Thorough surgical training programs are required to ensure physicians avoid localized damage to nerves in the pathway between the incision…

Georgia Bio Names GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award Winner

Georgia Bio, the state’s life science trade association, named GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award recipients. The Innovation Award recognizes the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology.   In early 2020, U.S. frontline healthcare…

Preclinical testing’s role in the medical device design and development phase

In the context of GCMI’s phase-gated product development, the “Design and Development” phase (also called “Phase 2” at GCMI) typically follows a Project Planning phase (called “Phase 1” at GCMI). At the completion of project planning, innovators have determined what work is required to take the technology from prototype to product. The Design and Development…

Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest

There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive.   As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…